flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 in Patients with Obesity-Related Heart Failure and Type 2 Diabetes ADA 24: FLOW Trial: Kidney

You can ask a 6 year old what chia seeds are, and not only do they know what chia seeds are, they can also tell you how to make a pudding

Together, these strains create a less hostile gut environment that may reduce the intensity and duration of nausea episodes

Patients carrying certain GLP1R variants may experience stronger initial nausea signals but often show better long-term tolerance and metabolic outcomes

Animals and cachexia model The mouse colon cancer cell line, CT26, which shows high tumorigenicity and low metastatic potential [29], was implanted into mice to generate an in vivo cancer cachexia model [8, 29, 30]

2008;29(S3):124-126

S6 show that both GLP-1RA and SGLT-2 inhibitors were associated with a lower risk (13% and 14%, respectively) as compared with placebo and DPP-4 inhibitors (11% and 12%, respectively), although the difference in risks was significant for SGLT-2 vs DPP-4 inhibitors only